Clinical Trial

Re-optimization Based Online Adaptive Radiotherapy of Anal Cancer

Study acronym: ROAR-A
Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated September 25, 2023 (before its estimated January 1, 2026 completion). Its status may not reflect the trial's current state.
Summary
A single-arm, prospective, Phase II, single-center clinical trial that will investigate if daily online adaptive radiotherapy for anal cancer will significantly reduce early treatment-related GI toxicity compared with the historically reported rate for non-adaptive intensity modulated radiation therapy (IMRT).
Protocol Amendment History 2 amendments
This ClinicalTrials.gov record has been amended 2 times since 2022-06-27; most recent amendment 2023-09-21.
Trial Details
NCT Number NCT05438836
Lead Sponsor Herlev Hospital
Conditions Anal Cancer, Anal Carcinoma, Anal Squamous Cell Carcinoma
Enrollment 205 participants
Start Date 2022-01-01
Primary Completion 2026-01-01 (estimated)
Study Completion 2031-01-01 (estimated)
Updated on ClinicalTrials.gov 2023-09-25